Published in Blood Weekly, December 13th, 2001
"Breast cancer resistance protein (BCRP) is a recently described member of the ATP binding cassette transporter superfamily," explained Jean M. Sargent and colleagues at Pembury Hospital in Kent, U.K., and the Vrije University Medical Centre and the Netherlands Cancer Institute in Amsterdam. "It has been shown to confer resistance to mitoxantrone, topotecan, doxorubicin and daunorubicin in human tumor cell lines."
A substantial proportion of blast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.